Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 901.19 |
| Open | 901.26 |
| Bid | 825.40 x 100 |
| Ask | 893.98 x 100 |
| Day's Range | 892.15 - 908.81 |
| 52 Week Range | 684.81 - 998.33 |
| Volume | |
| Avg. Volume | 473,780 |
| Market Cap | 98.126B |
| Beta (5Y Monthly) | 0.14 |
| PE Ratio (TTM) | 25.69 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
- Zacks
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- Zacks
Why Regeneron (REGN) Could Beat Earnings Estimates Again
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
© 2024 Yahoo. All rights reserved.